Melanoma-BMmelanomaLUAD-BMsolid tumors
…ferating B and T-cells, suggesting potential effector function. Melanoma-BM LAs also had increased intratumoral CD8+T-cells, unlike LUAD-BM…
190articles mentioning diseases
354disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Solid tumors ×
Solid tumors
This disease is selected. Its supporting articles are shown below.
Articles mentioning Solid tumors
190 articles · page 6 of 16solid tumorsANK-101NCT06171750tolododekin alfa
…an phase 1 clinical trial of superficially accessible, advanced solid tumors. Herein, we report pharmacokinetic (PK), anti-drug antibody (AD…
solid tumorscolorectal and pancreatic cancersavelumabutomilumabPF-04518600The University of Texas MD Anderson Cancer CenterPfizeranti-OX40anti-4-1BBOX40
…ss low immune permissive tumor states in patients with advanced solid tumors.Trial Registration NCT03217747Acknowledgements The study was fi…
Multiple myelomamyelomasolid tumorsCD73CD73 CAReLife
…3-CAR-NK cells resulted in potent antitumor activity in vivo. 1 Multiple myeloma is a plasma cell cancer that develops in the bone marrow and re…
Solid tumorsPD-L1-EphA2-4-1BBPD-L1-EphA2-CD28EphA2-PD-L1-4-1BBPD-L1-EphA2CAR-T therapyEphA2-PD-L1-CD28
…Background Solid tumors present a major challenge to CAR-T therapy due to antigen heter…
hematological cancersolid tumorsgraft-versus-host diseasesolid cancerChimeric antigen receptor T (CAR-T) cell therapiesxenograft mouse models
… that has shown promising clinical efficacy, especially against hematological cancer, with multiple FDA-approved therapies. Current autologous CART …
solid tumorsHNSCCStemcell TechnologiesNat Rev Immunol
…provides a basis for the improvement of immunotherapies against solid tumors by manipulating DNA repair.References Wherry EJ, Kurachi M. Mol…
97.5%
solid tumorsblood cancersrimiducidIL-2CLDN6-specificCLDN6
…R-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. Nat Med. 2023;29:2844–2853.Hambur…
solid tumorshuman cancersPC3 prostate cancerhuman prostate cancerDana-Farber Cancer InstituteBrigham and Women’s Hospital Crimson CoreCARM1
…dentify additional genetic regulators of CAR-T cell activity in solid tumors.Ethics Approval The animal work described in this abstract was …
solid tumors
…Background The efficacy of CAR-T cells against solid tumors is limited by the suppressive tumor microenvironment and T cell…
solid tumorstype I interferonNSGImmune-based therapiesSCID-Beige xenograft mouse models
…on was implemented. Two clinical development programs targeting solid tumors are currently underway. These CAR constructs will be integrated…
solid tumorsPBS
…olytic virus (OV) therapies face limited efficacy alone against solid tumors. We have shown that combining CAR T cell and VSV (vesicular sto…